News and Announcements
SUDA Amends Agreement with Amherst Pharmaceuticals
- Published December 11, 2015 11:49AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
10th December 2015, ASX Announcement
SUDA Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, today announces that it has amended its agreement with Amherst Pharmaceuticals in relation to ZolpiMist for insomnia and SUD-002 for nausea and vomiting.
Under the terms of the new agreement, SUDA has expanded it territorial rights to ZolpiMist to include South America, Central America and South America. As a result, SUDA now has a global license, excluding North America , to this US-registered oral spray of zolpidem tartrate for the treatment of insomnia. As per the cross-licencing agreement signed in January 2015, SUDA will pay Amherst a 6 to 12 per cent share of income from SUDA’s commercialisation of ZolpiMist. Business development discussions with prospective partners are progressing in several countries, including in the expanded territory.
To read the full announcement, please click here.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
